-
- Medicines
Extensive portfolio of the pharmaceutical service provider actively supports product development for injectable medicines in early and late clinical phases
Participated in eight market launches of customer products in 2023
– Balance Sheet 2023: Vetter successfully brings eight customer products to market
– As a market leader in Fill & Finish, the reliable service provider has established itself in early and late-phase drug development
– Vetter supports customers with medications in clinical phases through strategic cons…








